A recent study reveals how plants activate a reactive oxygen species (ROS)-driven signaling pathway to adapt to low nitrate ...

Cell-surface proteins are critical therapeutic targets and are vital to cellular communication, signaling, and homeostasis. However, developing high-affinity probes such as aptamers against these ...

A research team led by Prof. TAN Weihong and Prof. WU Qin from the Hangzhou Institute of Medicine (HIM) of the Chinese Academy of Sciences has developed a pioneering, multi-modal platform called SPARK ...

A ‘green channel’ and ‘white list’ system will allow samples and data to cross between innovation hubs in Lok Ma Chau and ...

China's Shenzhou-21 and the Tiangong space station in the orbit Photo: IC. China carried out 31 new space science and application projects to its space station in 2025, covering f ...

For most people, the loss of a sense such as sight is devastating, not only for intensifying vulnerability, but for ...

Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced that Kartik Ramamoorthi, Ph.D., Chief Executive ...

Ultragenyx Pharmaceutical ( ($RARE) ) just unveiled an update. On December 30, 2025, Ultragenyx Pharmaceutical announced it had completed the ...

Linker Vision, a leading AI software platform company specializing in Physical AI and Reasoning AI technologies, today announced the successful close of its US$35 million Series A funding round led by ...

Cell-surface proteins are critical therapeutic targets, and are vital to cellular communication, signaling, and homeostasis. However, developing ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...